Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008

Drug and Alcohol Dependence

Volumn 125, Issue 1-2, 2012, Pages 160-163

  Rosca, Paula ^a   Haklai, Ziona ^a   Goldberger, Nehama ^a   Zohar, Peres ^a   Margolis, Anatoly ^a   Ponizovsky, Alexander M ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

Dependence; Israel; Methadone; Mortality; Opioid

Indexed keywords

METHADONE;

AGE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG INTOXICATION; ETHNICITY; FEMALE; HUMAN; ISRAEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OPIATE ADDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; STANDARDIZED MORTALITY RATIO; SUDDEN DEATH;

ADOLESCENT; ADULT; AGE FACTORS; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; EMIGRANTS AND IMMIGRANTS; ETHNIC GROUPS; FEMALE; HUMANS; ISRAEL; MALE; MEDICAL RECORD LINKAGE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; SEX FACTORS; YOUNG ADULT;

EID: 84865035068     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.03.013     Document Type: Article

References (22)

1. Albion C., Shkrum M., Cairns J. Contributing factors to methadone-related deaths in Ontario. Am. J. Forensic Med. Pathol. 2010, 31:313-319.
2. American Psychiatric Association DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC.
3. Amin J., Dore G.J., O'Connel D.L., Bartlett M., Tracey E., Kaldor J.M., Law M.G. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J. Hepatol. 2006, 45:197-203.
4. Cornish R., Macleod J., Strang J., Vickerman P., Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. Br. Med. J. 2010, 341:c5475.
5. Darke S., Kaye S., Duflou J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes. Addiction 2006, 101:1771-1777.
6. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011, 106:32-51.
7. Gal G., Goldberger N., Kabaha A., Haklai Z., Geraisy N., Gross R., Levav I. Suicidal behavior among Muslim Arabs in Israel. Soc. Psychiatry Psychiatr. Epidemiol. 2012, 47:11-17.
8. Goldberger N., Aburbeh M., Haklai Z. Leading Causes of Death in Israel 1999-2008 2011, Ministry of Health, Available at http://www.health.gov.il/pages/default.asp?maincat=2&catid=841&pageid=4433. Accessed on 15/8/2011 (in Hebrew).
9. Grinshpoon A., Barchana M., Lipshitz I., Rosca P., Weizman A., Ponizovsky A.M. Methadone maintenance and cancer risk: an Israeli case registry study. Drug Alcohol Depend. 2011, 119:88-92.
10. Haklai, Z., Goldberger, N., Stein, N., Pugachova I., Levav I., in press. The mortality risk among persons with psychiatric hospitalizations. Isr. J. Psychiatry Relat. Sci.
11. Isralowitz R., Reznik A., Spear S.E., Brecht M.L., Rawson R.A. Severity of heroin use in Israel: comparisons between native Israelis and former Soviet Union immigrants. Addiction 2001, 102:630-637.
12. Kisely S., Smith M., Lawrence D., Cox M., Campbell L.A., Maaten S. Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ 2007, 176:779-784.
13. Lawrence D., Kisely S., Pais J. The epidemiology of excess mortality in people with mental illness. Can. J. Psychiatry 2010, 55:752-760.
14. Loebstein R., Mahagna R., Maor Y., Kurnik D., Elbaz E., Halkin H., Olchovsky D., Ezra D., Almog S. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Isr. Med. Assoc. J. 2008, 10:775-778.
15. Neumark Y., Friedlander Y., Bar-Hamburger R. Family history and other characteristics of heroin-dependent Jewish males in Israel: results of a case-control study. Isr. Med. Assoc. J. 2002, 4:766-771.
16. Ott J.J., Paltiel A.M., Becher H. Noncommunicable disease mortality and life expectancy in immigrants to Israel from the former Soviet Union: country of origin compared with host country. Bull. World Health Organ. 2009, 87:20-29.
17. Peles E., Schreiber S., Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 2010, 107:141-148.
18. Sanchez-Carbonell X., Seus L. Ten-year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction 2000, 95:941-948.
19. Shiels M.S., Cole S.R., Mehta S.H., Kirk G.D. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J. Acquir. Immune Defic. Syndr. 2010, 55:510-515.
20. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
21. Wilson M., Daly M., Pound N. An Evolutionary Psychological Perspective on the Modulation of Competitive Confrontation and Risk-Taking 2002, 381-408. Academic Press, San Diego, CA. D.W. Pfaff, A.P. Arnold, A.M. Etgen, S.E. Fahrbach, R.T. Rubin (Eds.).
22. World Health Organization The ICD-10 Classification of Mental and Behavioral Disorders. Diagnostic Criteria for Research 1993, WHO, Geneva.